Colony-Stimulating Factors for Febrile Neutropenia

被引:4
作者
Ishiguro, Hiroshi [1 ]
Toi, Masakazu [1 ]
机构
[1] Kyoto Univ Hosp, Kyoto 606, Japan
关键词
D O I
10.1056/NEJMc1306109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
<p id="p001">Colony-Stimulating Factors for Febrile Neutropenia during Cancer Therapy Clinical Therapeutics, N Engl J Med 2013;368:1131-1139. In the final paragraph of the Clinical Use section (page 1137), the doses for filgrastim should have been 300-g and 480-g vials and 350 g, rather than 300-mg and 480-mg vials and 350 mg. The article is correct at NEJM.org.
引用
收藏
页码:284 / 284
页数:1
相关论文
共 4 条
[1]   Colony-Stimulating Factors for Febrile Neutropenia during Cancer Therapy [J].
Bennett, Charles L. ;
Djulbegovic, Benjamin ;
Norris, LeAnn B. ;
Armitage, James O. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (12) :1131-1139
[2]   Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim [J].
Ishiguro, H. ;
Kitano, T. ;
Yoshibayashi, H. ;
Toi, M. ;
Ueno, T. ;
Yasuda, H. ;
Yanagihara, K. ;
Garbo, C. L. ;
Fukushima, M. .
ANNALS OF ONCOLOGY, 2008, 19 (05)
[3]  
Masuda N, 2011, EUR MULT CANC C STOC
[4]   A Pharmacokinetic and Dose Escalation Study of Pegfilgrastim (KRN125) in Lung Cancer Patients with Chemotherapy-induced Neutropenia [J].
Yamamoto, Nobuyuki ;
Sekine, Ikuo ;
Nakagawa, Kazuhiko ;
Takada, Minoru ;
Fukuoka, Masahiro ;
Tanigawara, Yusuke ;
Saijo, Nagahiro .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (07) :425-430